Recent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) | Abstract Continue ReadingRecent Research Development of Imeglimin as Oral Hypoglycemic Agent (OHA) | Abstract
Diabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg) | Abstract Continue ReadingDiabetic Elderly with Keeping Less Arteriosclerosis Treated by Imeglimin (Twymeeg) | Abstract
Latest Pharmaceutical Development of Imeglimin Electrospinning Nanofibers for Diabetic Treatment | Abstract Continue ReadingLatest Pharmaceutical Development of Imeglimin Electrospinning Nanofibers for Diabetic Treatment | Abstract
Improvement of HbA1c, Weight and Fatty Liver by Short Treatment of Imeglimin (Twymeeg) | Abstract Continue ReadingImprovement of HbA1c, Weight and Fatty Liver by Short Treatment of Imeglimin (Twymeeg) | Abstract
